BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15843997)

  • 1. Efficacy of AIDS vaccine strategies in nonhuman primates.
    Uberla K
    Med Microbiol Immunol; 2005 Aug; 194(4):201-6. PubMed ID: 15843997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an AIDS vaccine: the role of nonhuman primates.
    Nathanson N; Mathieson BJ
    J Med Primatol; 1999; 28(4-5):146-53. PubMed ID: 10593479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of an HIV-1 vaccine.
    Letvin NL
    Science; 1998 Jun; 280(5371):1875-80. PubMed ID: 9632379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.
    Clarke DK; Nasar F; Chong S; Johnson JE; Coleman JW; Lee M; Witko SE; Kotash CS; Abdullah R; Megati S; Luckay A; Nowak B; Lackner A; Price RE; Little P; Kalyan N; Randolf V; Javadian A; Zamb TJ; Parks CL; Egan MA; Eldridge J; Hendry M; Udem SA
    J Virol; 2014 Jun; 88(12):6690-701. PubMed ID: 24696472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
    Staprans SI; Feinberg MB; Shiver JW; Casimiro DR
    Curr Opin HIV AIDS; 2010 Sep; 5(5):377-85. PubMed ID: 20978377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.
    Del Prete GQ; Lifson JD; Keele BF
    Curr Opin HIV AIDS; 2016 Nov; 11(6):546-554. PubMed ID: 27559710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of a vaccine against HIV: is this aim accomplishable?].
    Wagner R; Asbach B
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of nonhuman primates in the development of an AIDS vaccine.
    Nathanson N; Hirsch VM; Mathieson BJ
    AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV vaccine pipeline, from preclinical to phase III.
    Schultz AM; Bradac JA
    AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of replication-competent viral vectors for HIV vaccine delivery.
    Parks CL; Picker LJ; King CR
    Curr Opin HIV AIDS; 2013 Sep; 8(5):402-11. PubMed ID: 23925000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating HIV vaccine development using non-human primate models.
    Rahman MA; Robert-Guroff M
    Expert Rev Vaccines; 2019 Jan; 18(1):61-73. PubMed ID: 30526159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 vaccines and adaptive trial designs.
    Corey L; Nabel GJ; Dieffenbach C; Gilbert P; Haynes BF; Johnston M; Kublin J; Lane HC; Pantaleo G; Picker LJ; Fauci AS
    Sci Transl Med; 2011 Apr; 3(79):79ps13. PubMed ID: 21508308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New directions for HIV vaccine development from animal models.
    McChesney MB; Miller CJ
    Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-human primate models for AIDS vaccine research.
    Hu SL
    Curr Drug Targets Infect Disord; 2005 Jun; 5(2):193-201. PubMed ID: 15975024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.